Q3 2021 13F Holders as of 9/30/2021
-
Type / Class
-
Equity / COM
-
Number of holders
-
767
-
Total shares
-
323M
-
Shares change
-
+4.09M
-
Total reported value, excl. options
-
$12.4B
-
Value change
-
+$152M
-
Put/Call ratio
-
0.38
-
Number of buys
-
345
-
Number of sells
-
-291
-
Price
-
$38.21
Significant Holders of GSK PLC ADR FSPONSORED ADR 1 ADR REPS 2 ORD SHS - COM (GSK) as of Q3 2021
779 filings reported holding GSK - GSK PLC ADR FSPONSORED ADR 1 ADR REPS 2 ORD SHS - COM as of Q3 2021.
GSK PLC ADR FSPONSORED ADR 1 ADR REPS 2 ORD SHS - COM (GSK) has 767 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 323M shares
.
Largest 10 shareholders include Dodge & Cox (88M shares), Capital International Investors (22.7M shares), Fisher Asset Management, LLC (17.8M shares), FMR LLC (17.3M shares), PRICE T ROWE ASSOCIATES INC /MD/ (14.8M shares), Black Creek Investment Management Inc. (10.3M shares), RENAISSANCE TECHNOLOGIES LLC (9.41M shares), HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC (9.13M shares), STATE STREET CORP (9.08M shares), and UBS Group AG (7.24M shares).
This table shows the top 767 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.